Roivant Sciences Ltd. (ROIVW)
NASDAQ: ROIVW
· Real-Time Price · USD
2.75
0.12 (4.56%)
At close: Jan 16, 2025, 10:00 PM
Roivant Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Net Income | -273.91M | -252.38M | -157.64M | -187.1M | 57.49M | -182.5M | 5.07B | -331.12M | -327.85M | -60.86M | -352.01M |
Depreciation & Amortization | 1.1M | 1.43M | -48.36M | 1.82M | 4.88M | 5.22M | 5.38M | 5.59M | 5.84M | 5.95M | 6.97M |
Stock-Based Compensation | 82.18M | 83.49M | 83.68M | 71.67M | 50.19M | 46.72M | 54.33M | 49.32M | 49.26M | 25.28M | n/a |
Other Working Capital | -25.42M | 34.65M | -53.16M | 3.1M | -43.47M | -4.93M | 29.54M | 18.93M | -47.18M | 30.79M | -4.46M |
Other Non-Cash Items | 23.42M | -39.59M | -31.83M | -163.5M | -236.66M | 6.13M | -5.36B | 62.66M | 58.06M | -170.64M | 119.71M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -37.17M | 34.48M | -53.1M | 10.31M | -68.73M | 15.96M | 21.2M | 17.13M | -35.24M | 21.18M | 2.74M |
Operating Cash Flow | -204.38M | -172.56M | -207.25M | -266.81M | -192.83M | -108.46M | -210.45M | -196.43M | -249.93M | -179.09M | -222.59M |
Capital Expenditures | -4.04M | -811K | -1.83M | -996K | -965K | -349K | -355K | -275K | -403K | -1.62M | -508K |
Cash Acquisitions | n/a | 74.93M | -110.39M | 110.39M | n/a | -804K | n/a | n/a | n/a | 114.56M | -3.09M |
Purchase of Investments | -1.8B | n/a | -658.54M | -3.4B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 720M | 1B | 960M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 79K | 264.82M | n/a | n/a | 8.08M | 5.23B | -36.18M | 508K | 614K | 88K |
Investing Cash Flow | -1.09B | 1.07B | 454.07M | -3.29B | -965K | 6.93M | 5.23B | -36.45M | 105K | 113.55M | -3.51M |
Debt Repayment | n/a | 58.59M | -49.09M | -1.83M | -1.83M | -7.66M | -7.57M | -7.81M | -7.81M | -8.04M | -7.42M |
Common Stock Repurchased | -208.29M | -295.44M | -243.35M | -106.05M | -648.38M | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 20.52M | -66.05M | 19.49M | -8.46M | -12.67M | 5.57M | -23.29M | 15.86M | 15.29M | 1.12M | -1.11M |
Financial Cash Flow | -187.77M | -177.15M | -272.95M | -109.07M | -660.62M | -32.62M | 236.64M | 207.87M | 7.48M | 210.33M | 154.5M |
Net Cash Flow | -1.48B | 723.99M | 32.04M | -3.66B | -857.15M | -135.01M | 5.26B | -26.46M | -242.47M | 151.08M | n/a |
Free Cash Flow | -208.42M | -173.38M | -209.08M | -267.8M | -193.79M | -108.81M | -210.81M | -196.7M | -250.34M | -180.71M | -223.1M |